California Public Employees Retirement System
KPTI icon

California Public Employees Retirement System’s Karyopharm Therapeutics KPTI Stock Holding History

California Public Employees Retirement System’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,533
Closed -$1.5M – 2258
2021
Q1 		$1.5M Sell
9,533
-882
-8% -$186K ﹤0.01% 2217
2020
Q4 		$2.42M Sell
10,415
-200
-2% -$46.3K ﹤0.01% 1880
2020
Q3 		$2.33M Buy
10,615
+163
+2% +$39.9K ﹤0.01% 1743
2020
Q2 		$2.97M Buy
10,452
+1,592
+18% +$471K ﹤0.01% 1550
2020
Q1 		$2.55M Sell
8,860
-11,469
-56% -$3.16M ﹤0.01% 1447
2019
Q4 		$5.85M Buy
20,329
+8,229
+68% +$1.79M 0.01% 1356
2019
Q3 		$1.75M Buy
12,100
+1,427
+13% +$193K ﹤0.01% 1971
2019
Q2 		$959K Sell
10,673
-377
-3% -$30.3K ﹤0.01% 2192
2019
Q1 		$968K Hold
11,050
– – ﹤0.01% 2241
2018
Q4 		$1.55M Buy
11,050
+8,799
+391% +$1.48M ﹤0.01% 1899
2018
Q3 		$575K Buy
2,251
+920
+69% +$254K ﹤0.01% 2607
2018
Q2 		$339K Buy
+1,331
New +$329K ﹤0.01% 2796
2014
Q3 		– Sell
-333
Closed -$233K – 3788
2014
Q2 		$233K Buy
+333
New +$155K ﹤0.01% 3370
2014
Q1 		– Sell
-333
Closed -$112K – 3822
2013
Q4 		$112K Buy
+333
New +$92K ﹤0.01% 3512

Other funds holding KPTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

California Public Employees Retirement System's KPTI Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Karyopharm Therapeutics (KPTI) in Q2 2021, closing a stake of 9,533 shares — an estimated $1.5M sold.

California Public Employees Retirement System first reported a position in KPTI in Q4 2013 and held it in 14 quarters. The position peaked at $5.85M in Q4 2019. 153 funds tracked by Wall St. Rank hold KPTI as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Karyopharm Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 9,533 Karyopharm Therapeutics shares in Q2 2021, an estimated $1.5M.
  • California Public Employees Retirement System first reported a position in Karyopharm Therapeutics in Q4 2013 and held it in 14 quarters.
  • California Public Employees Retirement System's Karyopharm Therapeutics position peaked at $5.85M in Q4 2019.
  • 153 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.